Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhigen Hu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Environmental Research and Public Health|September 22, 2019
Using Improved Principal Component Analysis to Explore Construction Accident Situations from the Multi-Dimensional Perspective: A Chinese StudyBo Shao, Zhigen Hu, Dawei Liu
Bioorganic & Medicinal Chemistry Letters|September 12, 2007
Inhibitors of NF-kappaB derived from thalidomideEsperanza J Carcache de-Blanco, Bulbul Pandit, Zhigen Hu, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Structure-activity relationships studies of the anti-angiogenic activities of linomideJiandong Shi, Zili Xiao, Michael A Ihnat, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2013
Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of actionBulbul Pandit, Zhigen Hu, Somsundaram N Chettiar, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Conformationally restricted analogs of Combretastatin A-4 derived from SU5416Pui-Kai Li, Zili Xiao, Zhigen Hu, et al.
Bioorganic & Medicinal Chemistry|July 25, 2006
Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416Bulbul Pandit, Yanjun Sun, Ping Chen, et al.
Molecular Cancer Therapeutics|March 1, 2006
A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activitiesPui-Kai Li, Bulbul Pandit, Dan L Sackett, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2010
Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasomeChristopher Blackburn, Cynthia Barrett, Jonathan L Blank, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Bioconjugate Chemistry|October 27, 2025
Identification of a Novel Linker Enabling the Bioconjugation of a Cyclic Dinucleotide for the STING Antibody-Drug Conjugate TAK-500Hong Myung Lee, Kojo Abdul-Hadi, Vicky A Appleman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Environmental Research and Public Health|September 22, 2019
Using Improved Principal Component Analysis to Explore Construction Accident Situations from the Multi-Dimensional Perspective: A Chinese StudyBo Shao, Zhigen Hu, Dawei Liu
Bioorganic & Medicinal Chemistry Letters|September 12, 2007
Inhibitors of NF-kappaB derived from thalidomideEsperanza J Carcache de-Blanco, Bulbul Pandit, Zhigen Hu, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Structure-activity relationships studies of the anti-angiogenic activities of linomideJiandong Shi, Zili Xiao, Michael A Ihnat, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2013
Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of actionBulbul Pandit, Zhigen Hu, Somsundaram N Chettiar, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Conformationally restricted analogs of Combretastatin A-4 derived from SU5416Pui-Kai Li, Zili Xiao, Zhigen Hu, et al.
Bioorganic & Medicinal Chemistry|July 25, 2006
Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416Bulbul Pandit, Yanjun Sun, Ping Chen, et al.
Molecular Cancer Therapeutics|March 1, 2006
A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activitiesPui-Kai Li, Bulbul Pandit, Dan L Sackett, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2010
Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasomeChristopher Blackburn, Cynthia Barrett, Jonathan L Blank, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Bioconjugate Chemistry|October 27, 2025
Identification of a Novel Linker Enabling the Bioconjugation of a Cyclic Dinucleotide for the STING Antibody-Drug Conjugate TAK-500Hong Myung Lee, Kojo Abdul-Hadi, Vicky A Appleman, et al.
Pageof 2